CUSIP 766559702COMRIGLQ4 2025
12 filings · latest Feb 9, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 1.66M | $71.28M |
| 2 | State Street Corp | 1.09M | $46.74M |
| 3 | Vanguard Group Inc | 1.04M | $44.48M |
| 4 | Armistice Capital, LLC | 836.0K | $35.81M |
| 5 | Goldman Sachs Group Inc | 671.9K | $28.78M |
| 6 | Marshall Wace, LLP | 613.6K | $26.28M |
| 7 | Renaissance Technologies LLC | 539.0K | $23.09M |
| 8 | Millennium Management LLC | 431.5K | $18.48M |
| 9 |
| 4 | May 15, 2025 | Armistice Capital, LLC | 13G/A | 8.5% | 1.52M | SEC |
| 5 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 7.7% | 1.38M | SEC |
| 6 | Feb 14, 2025 | Armistice Capital, LLC | 13G/A | 6.5% | 1.15M | SEC |
| 7 | Feb 11, 2025 | Soleus Capital Master Fund, L.P. | 13G/A | 6.4% | 1.13M | SEC |
| 8 | Feb 7, 2025 | Invesco Ltd. | 13G/A | — | 6.4K | SEC |
| 9 | Feb 5, 2025 | Blackrock, Inc. | 13G | 9.9% | 1.75M | SEC |
| 10 | Nov 14, 2024 | Soleus Capital Master Fund, L.P. | 13G/A | 5.3% | 934.8K | SEC |
See the full Schedule 13D/13G history for Rigel Pharmaceuticals Inc.
Unlock full history| 424.3K |
| $18.18M |
| 10 | D. E. Shaw & Co., Inc. | 424.3K | $18.17M |